Macro: Sandcastle economics
Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.
Technical Analyst, Saxo Bank Group
Summary: Novo Nordisk is testing key support at 1,050. Close below can lead to heavy sell-off
Vestas Wind in downtrend short-term testing key support in medium-term range
DSV in strong uptrend both short- and medium-term
OMX C25 Index in down trend close to test key support
Novo Nordisk dipped yesterday below key strong support at around 1,050 for the fifth time only to bounce back and close above.
However, at the time of writing sellers are once again trying to push it below the support and this time they seems to be more succesful.
Share price is below 21 and 55 daily Moving Averages which are both declining and below 100 Moving Average and RSI is showing negative sentiment after closing below the 40 threshold a few days ago, suggesting Novo is likely to trade lower.
If Novo closes below 1,050 downtrend is confirmed
If that scenario plays out a sell-off down to around 970-950 could be seen.
To resume uptrend a close above 1,113.60 is needed.
Medium-term Novo has broken below upper rising trendline. RSI has been showing divergence at the peak indicating a weakening of the uptrend and a possible correction.
A daily closed below 1,050 could result in a larger correction to test the lower medium-term rising trendline
Vestas Wind is short-term in a confirmed downtrend trading in a steep falling channel like pattern.
Medium-term Vestas is close to breaking bearish out of sideways range. A weekly close below 173 combined with weekly RSI closing below 40 will confirm downtrend.
A down trend that could take Vestas to October 2022 levels around 131.
To establish a medium-term uptrend a close above 215.50 is needed.
DSV uptrend seems to be continuing. On both the daily and weekly charts RSI is showing positive sentiment with no divergence supporting the bullish trend that could take DSV higher. No strong resistance until around 1,527.
To demolish this bullish picture a close below 1,309 is needed.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)